Immatics N.V. Ordinary Shares - Grafik, Fiyat ve Haberler (NASDAQ:IMTX) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

Market Capitalization 15.43 M
Employee 407
Founded 2000
CEO Harpreet Singh
Website www.immatics.com
Headquarter Netherlands
FIGI N/A
Industry Biyoteknoloji

Haberler

Immatics NV kazancı €0,04 ile beklentilere göre daha kötü, kâr ise beklentilere göre düşük

Immatics (IMTX) Reports Q1 Loss, Lags Revenue Estimates

ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up

RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y

Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates

All You Need to Know About Immatics (IMTX) Rating Upgrade to Buy

NVO Q1 Earnings & Sales Top Estimates, 2026 Outlook Raised, Stock Up

Twist Bioscience (TWST) Reports Q2 Loss, Beats Revenue Estimates

TD Cowen, Immatics hissesi için alım tavsiyesi verdi

Immatics ASCO toplantısında dört sözlü sunum yapacak

Immatics: Buying The Anzu-Cel Floor, Playing The Moderna Moonshot (NASDAQ:IMTX)